Brain Tumor : News

Healthline's Premium Tools

Symptom Search
Discover possible causes based on the symptoms you enter. It's fast, convenient and easy to use.
Pill Finder
Search by color, shape and markings. click here
Drug Interaction Checker
Check any 2 drugs for interactions. click here
Drug Compare
Compare any two drugs side by side. click here
Healthline Part D Plan Selector Medicare Part D
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
... said. "We'll have three examples of that." Her segment will highlight new treatment for medulloblastoma, a malignant brain tumor that commonly targets children. ABC News' Gibson will report on breast cancer, he said, "because my wife has gone ...
Source:Batman movie earning money at record pace
Date:September 5, 2008
Researchers have mapped the genetic blueprint of two of the deadliest forms of cancer, detailing the mutations that lead to tumors of the pancreas and brain.
Source:WMFE
Date:September 5, 2008
... because she wasn't being productive at work. She has some tests done, and they found that she had some lesions in her brain, and it was cancerous." The news was devastating, but what her doctor said next was maybe even more so. Rose's cancer ...
Source:WFMY-TV Greensboro
Date:September 5, 2008
The most comprehensive to-date genomic analysis of a cancer - " the deadly brain tumor glioblastoma multiforme - " shows previously unrecognized changes in genes and provides an overall view of the missteps in ...
Source:Huliq.com
Date:September 5, 2008
The Food and Drug Administration has asked the manufacturers of Humira, Cimzia, Enbrel, and Remicade - which belong to a class of medications known as tumor necrosis factor alpha blockers - to strengthen the ...
Source:US News & World Report
Date:September 5, 2008
Scientists have mapped the cascade of genetic changes that turn normal cells in the brain and pancreas into two of the most lethal cancers.
Source:Berkshire EagBerkshire Eagle
Date:September 5, 2008
An international team of cancer experts reported Thursday that cancer is much more complicated than previously believed, and have discovered why curing the disease is so difficult once a tumor has spread.
Source:RedOrbit
Date:September 5, 2008
Cytopia Limited today announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer ...
Source:Med Ad News
Date:September 5, 2008
... technology that uses liposomes to deliver radiation through direct injection into head and neck tumors, shrinking the tumor, delaying recurrence and avoiding the collateral tissue damage that often accompanies all other forms of radiation therapy. ...
Source:Medical News Today
Date:September 5, 2008
The first dose of TYSABRI was administered yesterday in the trial. The objectives of this Phase I/II study are to evaluate the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or ...
Source:MarketWatch
Date:September 5, 2008
A massive scan of tumor samples from a Phoenix lab has revealed new genetic clues about an aggressive form of brain cancer, which could open the door to new treatments and explain why some patients don't ...
Source:Arizona Republic
Date:September 4, 2008
... suffered from an upper respiratory infection that she just could not kick. She sought doctors' opinions to no avail. A brain tumor was discovered, and doctors have watched it progress quickly to the point where it has caused changes in Jennifer's ...
Source:Aiken Standard
Date:September 4, 2008
... The healing exercise stretches and expands the energy meridians in the body to create balance and harmony between the brain and the body. The movements are simple, graceful gestures done mindfully and repetitively. No experience is necessary. A ...
Source:NewburyportNews.com, Newburyport, MA
Date:September 4, 2008
... studied for the treatment of cancer. The 40-patient trial is an open-label study to determine the safety and anti-tumor activity of Tysabri in patients with relapsed or refractory multiple myeloma. According to the companies, multiple myeloma is the ...
Source:Mass High Tech
Date:September 1, 2008
Advertisement
Back to Top